40% of patients with advanced lung cancer have no suspicious symptoms

  • A project in which the Hospital de Sant Pau participates is committed to screening programs for populations at risk.

O 40% of patients diagnosed with Cancer advanced lung cancer had not presented no suspicious symptoms before, according to the clinical head of the Department of Thoracic Surgery at the Hospital de la Santa Creu i Sant Pau, Juan Carlos Trujillo. O 85% of cases are diagnosed in advanced stage, when there are few healing options.

O main risk factor remains the smoke, but there is a 15% of cases occur in non-smokers. and often present tumors with molecular alterations. Therefore, the cassandra pilot project, with the participation of Sant Pau and led by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) is committed to the screening programs in higher-risk populations.

Several European and North American studies have shown that screening programs reduce mortality by 20% to 40%. of lung cancer and between 7% and 20% of overall mortality.

Trujillo highlighted that the project wants to go hand in hand with the. primary prevention and lung cancer screening. and those smoking-associated diseases with the participation of more than 10 Spanish scientific societies, patient associations and several health centers. Currently, one twenty hospitals Up to 14 autonomous communities have already joined.

The Cassandra Program

Cassandra offers annual lung cancer screenings nationwide. low-dose computed tomography (LDCT), which is the test indicated to detect this tumor, but also a smoking cessation program.

According to SEPAR data, 34% of the Spanish population smokes. While the habit declined in men after age 50, it rose sharply among young people and is currently on the rise among women.

In the case of the Hospital de Sant Pau, the following is carried out. multidisciplinary approach to patients with lung cancer. With regard to the latest innovations, immunotherapy is the first-line treatment in patients with advanced lung cancer and without contraindications, combined or not with chemotherapy. This one treatment it is also effective before and after surgery in localized disease and locally advanced disease after a radical chemotherapy and radiotherapy.

On the occasion of World Lung Cancer Day, which is celebrated on November 17, ICAPEM (Association for the Investigation of this Pathology) points out that more than 30,000 diagnoses are expected in 2022, a number that has been increasing in recent years, especially among women.

In addition, 30% of lung cancer diagnoses occur in non-smokers, a percentage that doubles that of men, which means that 2 out of 3 non-smokers who have this disease are women.

40% of patients with advanced lung cancer have no suspicious symptoms

Leave a Reply

Your email address will not be published.

Scroll to top